lifestyle.briefmobile.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Avidity Biosciences, Inc.
Avidity Biosciences Announces Multiple Upcoming Presentations at 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
April 30, 2026
Avidity Biosciences Announces Intention to Adjourn and Reconvene Special Meeting of Stockholders
April 29, 2026
The New England Journal of Medicine Publishes Results from Phase 1/2 MARINA® Trial of Delpacibart Etedesiran (del-desiran) for Treatment of Myotonic Dystrophy Type 1
April 28, 2026
Avidity Biosciences Announces Expected Record Date for Spin-Off
February 2, 2026
Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44
November 21, 2025